Differential expression of transforming growth factor-alpha and macrophage colony-stimulating factor/colony-stimulating factor-1R (c-fins) by multinucleated giant cells involved in pathological bone resorption at the site of orthopaedic implants.
The immunologic response to prosthetic biomaterial particles is characterized by macrophage-rich inflammatory infiltrate, formation of multinucleated giant cells, and aseptic loosening at the site of arthroplasty. We investigated the in vivo expression and tissue distribution of transforming growth factor alpha, macrophage colony-stimulating factor, and the receptor for colony-stimulating factor-1 at the site of bone erosion in patients with clinically failed orthopaedic implants (n = 30). The expression was further compared with that detected in the inflamed synovial membranes from patients with rheumatoid arthritis or osteoarthritis (n = 15) and one patient with osteoclastoma (giant cell tumour of bone). Immunostaining of the tissue demonstrated positivity for transforming growth factor alpha within the inflammatory macrophage and multinucleated giant cell infiltrate in the diseased synovial membrane and the bone-implant interface. A comparative analysis between the synovium and retrieval interface membranes (pseudosynovium) revealed a high level of expression of transforming growth factor alpha, with intense membrane staining on multinucleated giant cells in all failed arthroplasties with pseudosynovium. In addition, the frequency, antigenic phenotype, and pattern of transforming growth factor alpha expression on multinucleated giant cells in the interface were markedly similar to those observed for multinucleated giant cells in osteoclastoma. Multinucleated giant cells within the interface lacked the expression of macrophage colony-stimulating factor and colony-stimulating factor-1 receptor, whereas those at the bone surfaces exhibited strong immunoreactivity. The predominant expression of transforming growth factor alpha by multinucleated giant cells in the bone-implant interface and its similarity to osteoclastoma highlight the importance of assessing transforming growth factor alpha as a possible contributor to the development of bone-resorbing giant cells at the site of failed orthopaedic implants.
Al-Saffar
N
N
Department of Histopathology, Royal Free and University College Medical School, Hampstead, London, England. alsaffar@rfc.ucl.ac.uk
Revell
P A
PA
D001172:Arthritis, Rheumatoid / Q000378:metabolism / Q000473:pathology; D019644:Arthroplasty, Replacement, Hip; D019645:Arthroplasty, Replacement, Knee; D001859:Bone Neoplasms / Q000378:metabolism / Q000473:pathology; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000378:metabolism / Q000473:pathology; D019084:Fluorescent Antibody Technique, Indirect; D018212:Giant Cell Tumor of Bone / Q000378:metabolism / Q000473:pathology; D015726:Giant Cells / Q000378:metabolism* / Q000473:pathology; D006622:Hip Prosthesis; D006801:Humans; D007720:Knee Prosthesis; D016173:Macrophage Colony-Stimulating Factor / Q000096:biosynthesis*; D010003:Osteoarthritis / Q000378:metabolism / Q000473:pathology; D010014:Osteolysis / Q000378:metabolism* / Q000473:pathology; D016184:Receptors, Colony-Stimulating Factor / Q000096:biosynthesis*; D013583:Synovial Membrane / Q000378:metabolism / Q000473:pathology; D016211:Transforming Growth Factor alpha / Q000096:biosynthesis*
D016184:Receptors, Colony-Stimulating Factor; D016211:Transforming Growth Factor alpha; D016173:Macrophage Colony-Stimulating Factor